Protagenic Therapeutics, Inc.
(Other OTC/NBB : ATRN)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Technology Services » Internet Software Or Services
symbolcompany%chnglast%shortavg$volume
FBFacebook, Inc. Class A
1.28%162.090.7%$3554.21m
GOOGLAlphabet Inc. Class A
0.72%1112.140.4%$1903.35m
GOOGAlphabet Inc. Class C
0.95%1107.400.4%$1641.62m
TWTRTwitter, Inc.
2.54%31.549.3%$735.48m
BIDUBaidu, Inc. Sponsored ADR Class A
-2.78%167.032.4%$427.45m
GRUBGrubHub, Inc.
-0.19%79.3520.2%$325.33m
MELIMercadoLibre, Inc.
2.01%372.314.0%$185.77m
NTESNetEase, Inc. Sponsored ADR
1.41%222.010.8%$169.59m
WBWeibo Corp Sponsored ADR Class A
4.18%68.297.8%$138.31m
MTCHMatch Group, Inc.
0.49%57.014.4%$133.07m
CHKPCheck Point Software Technologies Ltd.
1.12%122.534.1%$120.48m
GDDYGoDaddy, Inc. Class A
-0.29%75.634.6%$111.47m
WIXWix.com Ltd.
0.87%109.631.9%$109.16m
VRSNVeriSign, Inc.
1.13%177.9911.5%$108.01m
MOMOMomo Inc Sponsored ADR Class A
4.68%33.091.9%$91.48m

Company Profile

Protagenic Therapeutics, Inc. is a biotechnology company, which specializes in the discovery and development of therapeutics to treat central nervous system disorders. It offers the PT00114 peptide-based formulations. The company was founded by Garo H. Armen, David A. Lovejoy and Hartoun Hartounian on February 3, 1994 and is headquartered in New York, NY.